Similarly, based on mutation data from the TCGA NSCLC cohort, the significantly enhanced TMB and NB were also found in the FASN mutant subgroup (p = 0.002 and 0.014; Figure 5D,E). Here, FASN is linked to non-small cell lung carcinoma.